Zine News

Myovant Sciences Completes Patient Recruitment for Phase 3 SPIRIT 2 Study Evaluating Relugolix Combination Therapy in Women with Endometriosis

- Top-line data for SPIRIT 2 expected in first quarter of 2020

Publicaciones relacionadas

Botón volver arriba
Cerrar